AUG 7, 2026 · PHASE 3 TRIAL
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
ClinicalTrials.gov
This is a Phase 3 trial registration with no results posted; enrollment is ongoing and outcomes have not yet been reported.
Reported
Planned enrollment310
PhasePHASE 3
Primary endpointProgression-Free Survival (PFS), up to appr…